Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP890227.RAabQ0hO86NpUKP7VjvJjNQtNaiuyD7KOvGnxsNBhqMfg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP890227.RAabQ0hO86NpUKP7VjvJjNQtNaiuyD7KOvGnxsNBhqMfg130_assertion type Assertion NP890227.RAabQ0hO86NpUKP7VjvJjNQtNaiuyD7KOvGnxsNBhqMfg130_head.
- NP890227.RAabQ0hO86NpUKP7VjvJjNQtNaiuyD7KOvGnxsNBhqMfg130_assertion description "[The recent regulatory approval of RAF inhibitors and a MAP-ERK kinase (MEK) inhibitor for metastatic melanoma provides clinical validation of tumor dependency on this pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890227.RAabQ0hO86NpUKP7VjvJjNQtNaiuyD7KOvGnxsNBhqMfg130_provenance.
- NP890227.RAabQ0hO86NpUKP7VjvJjNQtNaiuyD7KOvGnxsNBhqMfg130_assertion evidence source_evidence_literature NP890227.RAabQ0hO86NpUKP7VjvJjNQtNaiuyD7KOvGnxsNBhqMfg130_provenance.
- NP890227.RAabQ0hO86NpUKP7VjvJjNQtNaiuyD7KOvGnxsNBhqMfg130_assertion SIO_000772 24097822 NP890227.RAabQ0hO86NpUKP7VjvJjNQtNaiuyD7KOvGnxsNBhqMfg130_provenance.
- NP890227.RAabQ0hO86NpUKP7VjvJjNQtNaiuyD7KOvGnxsNBhqMfg130_assertion wasDerivedFrom befree-20150227 NP890227.RAabQ0hO86NpUKP7VjvJjNQtNaiuyD7KOvGnxsNBhqMfg130_provenance.
- NP890227.RAabQ0hO86NpUKP7VjvJjNQtNaiuyD7KOvGnxsNBhqMfg130_assertion wasGeneratedBy ECO_0000203 NP890227.RAabQ0hO86NpUKP7VjvJjNQtNaiuyD7KOvGnxsNBhqMfg130_provenance.